文献速递免疫规划传染病防控与疫情报告

马拉维规划性引入轮状病毒疫苗四年后疫苗对轮状病毒住院的直接和可能间接效应

Direct and possible indirect effects of vaccination on rotavirus hospitalisations among children in Malawi four years after programmatic introduction.
PubMed 文献 · Vaccine · 2018-06-07

在马拉维布兰太尔一家转诊医院纳入2320名5岁以下急性胃肠炎患儿,比较疫苗引入前与引入四年后轮状病毒流行率并估计疫苗效果。住院婴儿轮状病毒流行率从49.64%降至32.45%(调整RR 0.67,95%CI 0.55-0.82),调整疫苗效果为61.89%(95%CI 28.04-79.82),未接种婴儿流行率亦下降(RR 0.70,95%CI 0.55-0.80),提示可能存在间接效应。

要点

  • 住院婴儿轮状病毒流行率疫苗引入后较引入前下降,调整RR 0.67(95%CI 0.55-0.82)。
  • 12-23月龄儿童流行率下降幅度较小,调整RR 0.85(95%CI 0.57-1.28)。
  • 调整疫苗效果为61.89%(95%CI 28.04-79.82),12-23月龄儿童为31.69%(95%CI -139.03至80.48)。

核心结论

  • 马拉维引入轮状病毒疫苗后,急性胃肠炎住院患儿轮状病毒流行率显著下降,婴儿中可见一定间接效应证据;轮状病毒仍是马拉维儿童严重腹泻的重要原因,尤其在出生后第二年。

研究设计与样本

  • 研究纳入5岁以下到布兰太尔一家转诊医院就诊的急性胃肠炎患儿,共2320名,使用酶免疫法检测粪便轮状病毒。
  • 采用泊松回归评估轮状病毒流行率变化,时间序列分析进一步调查流行率随时间趋势,逻辑回归估计任何严重程度轮状病毒腹泻的疫苗效果,并通过未接种儿童流行率随时间变化及比较观察到的住院减少与基于疫苗覆盖率和试验效力估计的预期减少来评估间接效应。

主要发现

  • 住院婴儿(<12月龄)急性胃肠炎中轮状病毒流行率从疫苗引入前的69/139(49.64%)降至引入后的197/607(32.45%),调整RR 0.67(95%CI 0.55-0.82)。
  • 12-23月龄儿童流行率从疫苗引入前的15/37(40.54%)降至引入后的122/352(34.66%),调整RR 0.85(95%CI 0.57-1.28)。
  • 调整疫苗效果为61.89%(95%CI 28.04-79.82),12-23月龄儿童为31.69%(95%CI -139.03至80.48)。
  • 在轮状病毒病住院婴儿中,观察到的疫苗总体效果比根据疫苗覆盖率和效力估计的预期值高9%。
  • 未接种婴儿中轮状病毒流行率在疫苗引入后下降(RR 0.70,95%CI 0.55-0.80)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Despite increased use of vaccine in routine immunisation, rotavirus remains a major cause of acute gastroenteritis (AGE) in low-income countries. We describe rotavirus prevalence and hospitalisation in Malawi pre and four years post vaccine introduction; provide updated vaccine effectiveness (VE) estimates; and assess rotavirus vaccine indirect effects. METHODS: Children under five years of age presenting to a referral hospital in Blantyre with AGE were recruited. Stool samples were tested for rotavirus using Enzyme Immunoassay. The change in rotavirus prevalence was evaluated using Poisson regression. Time series analysis was used to further investigate trends in prevalence over time. VE against rotavirus diarrhoea of any severity was estimated using logistic regression. Indirect effects were estimated by evaluating rotavirus prevalence in unvaccinated children over time, and by comparing observed reductions in incidence of rotavirus hospitalisation to those expected based on vaccine coverage and trial efficacy estimates. RESULTS: 2320 children were included. Prevalence of rotavirus in hospitalised infants (<12 months) with AGE decreased from 69/139(49.64%) prior to vaccine introduction to 197/607(32.45%) post-vaccine introduction (adjusted RR 0.67[95% CI 0.55, 0.82]). Prevalence in children aged 12-23 months demonstrated a less substantial decline: 15/37(40.54%) pre- and 122/352(34.66%) post-vaccine introduction (adjusted RR 0.85, 95% CI 0.57, 1.28). Adjusted VE was 61.89%(95% CI 28.04-79.82), but lower in children aged 12-23 months (31.69% [95% CI -139.03 to 80.48]). In hospitalised infants with rotavirus disease, the observed overall effect of the vaccine was 9% greater than expected according to vaccine coverage and efficacy estimates. Rotavirus prevalence among unvaccinated infants declined post-vaccine introduction (RR 0.70[95% CI 0.55-0.80]). CONCLUSIONS: Following rotavirus vaccine introduction in Malawi, prevalence of rotavirus in hospitalised children with AGE has declined significantly, with some evidence of an indirect effect in infants. Despite this, rotavirus remains an important cause of severe diarrhoea in Malawian children, particularly in the second year of life.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Bennett A, Pollock L, Jere KC, et al. Direct and possible indirect effects of vaccination on rotavirus hospitalisations among children in Malawi four years after programmatic introduction. Vaccine. 2018. PMID: 29887320. doi:10.1016/j.vaccine.2018.04.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。